Conversely, fibroblast-specific overexpression of ATF3 (driven by Col1a2-Cre) improves cardiac function and remodeling after MI [110], thus confirming that activation of cardiac fibroblast ATF3 represents a potential therapeutic strategy for improving cardiac remodeling and function. Here, ATF3 is linked to myocardial infarction.